By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Assessing Shiba Inu and Dogecoin as Crypto's Meme Coin War Heats Up
Tonya Evans, professor at Penn State Dickinson Law, joined Cheddar to talk about the meme coin war flaring up between the Shiba Inu and Dogecoin tokens. She noted that one of the most fascinating takeaways from the crypto craze is the "power of community" being able to manipulate market prices. Evans also talked about the rising number of coins coming to market and how to assess if they are worth investing in.
Facebook Rebrands to Meta, Gives a Glimpse into Internet of the Future
Social media giant 'Facebook' has rebranded itself as 'Meta' in a move that has many talking about the motive behind the timing of the announcement as the company finds itself getting negative press almost daily. Editor In Chief of Investopedia Caleb Silver breaks down the change and how the vision of Meta and the Metaverse could change the future.
Shopify Q3 Earnings Fall Short of Estimates
Third quarter Shopify earnings fell below expectations in both revenue and earnings per share. Though the e-commerce retailer has seen growth in partnerships with Target and Spotify, as well as adoption of a buy now, pay later payment option, Hatem Dhiab, Managing Partner at Gerber Kawasaki explains the impact that ongoing supply chain issues have had on Shopify's bottom line.
What's Behind the Facebook Inc. Name Change to Meta
Nicola Mendelsohn, vice president of the global business group at the newly-christened Meta, joined Cheddar to discuss what went into the re-branding of Facebook's parent company. Regarding criticism that the name change might be a way for the company to deflect from news of its role in allegedly undermining child safety, growing political strife, and spreading vaccine disinformation, she noted that the process began even earlier. "Something like this takes a long time to pull together," Mendelsohn said.
Load More